The legacy of Viagra, and its developer copyright, presents a intriguing case study for investors. Initially a blockbuster drug, producing billions in income, its intellectual property lapse created a flood of knock-off medications, significantly eroding its dominance. While certain firms may try to capitalize on related treatments , the current… Read More